Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
Tags Europe: Top News And Analysis Novo Nordisk A/S Europe News
From CNBC.com News
Ozempic underworld: Inside the black market of obesity drugs
Tags Health care industry Novo Nordisk A/S Crime
From CNBC.com News
CNBC Daily Open: October’s gravity bringing stocks down
Tickers JOBS OIL
Tags Markets NVIDIA Corp Market Outlook
From CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
Tags PDD Holdings Inc Delta Air Lines Inc PepsiCo Inc/
From CNBC.com News
Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
Tags Eli Lilly and Co State of Freight Marine Ports and Services
From CNBC.com News
East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
Tags Strikes US Economy U/S/ Economy
From CNBC.com News
Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
Tags Health care industry Novo Nordisk A/S Biotech and Pharmaceuticals
From CNBC.com News
5 things to know before the stock market opens Wednesday
Tags Investing Business NVIDIA Corp
From CNBC.com News
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
Tags Health care industry Biotech and Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
Tags US: News Eli Lilly and Co Biotechnology
From CNBC.com News
Tuesday's big stock stories: What's likely to move the market in the next trading session
Tags Eli Lilly and Co PRO: Playbooks Stock markets
From CNBC.com News
Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
Tickers NEWS NVO
Tags News Health Care Edge Project
From Benzinga
FTC sues drug middlemen for allegedly inflating insulin prices
Tags CVS Health Corp Breaking News: Politics Sanofi SA
From CNBC.com News
Novartis not joining the 'frenzy' of weight loss drugs, CEO says
Tags Biotechnology Health & Science Eli Lilly and Co
From CNBC.com News
Healthy Returns: How competitive can Roche be in the weight loss drug market?
Tags Novo Nordisk A/S Biotech and Pharmaceuticals Roche Holding AG
From CNBC.com News
How the Research Triangle has helped make North Carolina one of America's fastest-growing economies
Tags Business Retail Earnings
From CNBC.com News
CNBC Daily Open: All key data is in — and it's made the Fed's policy path more uncertain
Tickers JOBS
Tags Markets Oracle Corp Jobs
From CNBC.com News
Eli Lilly to invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer's drugs
Tags Health care industry Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs
Tags Health & Science Apple Inc Social issues
From CNBC.com News
Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock
Tags Biotech and Pharmaceuticals Novo Nordisk A/S Berkshire Hathaway Inc
From CNBC.com News
5 things to know before the stock market opens Tuesday
Tags Economy Novo Nordisk A/S Technology
From CNBC.com News
Weight loss drugs cut Covid-19 deaths, study finds
Tags Europe News Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Tags Health care industry Biotech and Pharmaceuticals Pharmaceuticals
From CNBC.com News
Health-care system Sesame to offer compounded versions of Wegovy through new $249 weight loss program
Tags US: News Health & Science Biotechnology
From CNBC.com News
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
Tags Science US: News Eli Lilly and Co
From CNBC.com News
What's next for the Biden administration's Medicare drug price negotiations
Tags Novo Nordisk A/S Pharmaceuticals Biotech and Pharmaceuticals
From CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
Tags Politics Companies Social issues
From CNBC.com News
Healthy Returns: Eli Lilly gains momentum against Novo Nordisk in the weight loss drug market
Tags Health & Science Healthy Returns Biotech and Pharmaceuticals
From CNBC.com News
Digital health company Ro launches GLP-1 insurance-coverage checker to help patients navigate costs
Tags Health care industry Companies Breaking news
From CNBC.com News
Eli Lilly's Zepbound and Mounjaro now available in U.S. after shortages, FDA says
Tags Health & Science Business Biotechnology
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.